- $2.61m
- -$2.02m
- $8.26m
- 48
- 76
- 11
- 41
Annual income statement for My Size, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.142 | 0.131 | 4.46 | 7 | 8.26 |
| Cost of Revenue | |||||
| Gross Profit | 0.14 | 0.131 | 0.634 | 2.73 | 3.32 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.29 | 10.7 | 12.6 | 13.7 | 12.2 |
| Operating Profit | -6.15 | -10.6 | -8.11 | -6.74 | -3.94 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -6.16 | -10.5 | -8.35 | -6.71 | -4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.16 | -10.5 | -8.31 | -6.38 | -4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.16 | -10.5 | -8.31 | -6.38 | -4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.16 | -10.5 | -8.31 | -6.38 | -4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -222 | -200 | -59.4 | -18.6 | -3.69 |
| Dividends per Share |